NHNK.Y Stock Overview
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for NHNK.Y from our risk checks.
Nihon Kohden Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥13.42 |
| 52 Week High | JP¥16.35 |
| 52 Week Low | JP¥11.22 |
| Beta | 0.017 |
| 1 Month Change | 2.21% |
| 3 Month Change | -10.65% |
| 1 Year Change | -4.42% |
| 3 Year Change | -11.59% |
| 5 Year Change | -5.56% |
| Change since IPO | 29.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| NHNK.Y | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -3.2% |
| 1Y | -4.4% | -3.7% | 19.3% |
Return vs Industry: NHNK.Y matched the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: NHNK.Y underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| NHNK.Y volatility | |
|---|---|
| NHNK.Y Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NHNK.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: NHNK.Y's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 5,751 | Hirokazu Ogino | www.nihonkohden.com |
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers.
Nihon Kohden Corporation Fundamentals Summary
| NHNK.Y fundamental statistics | |
|---|---|
| Market cap | US$2.27b |
| Earnings (TTM) | US$104.47m |
| Revenue (TTM) | US$1.41b |
21.7x
P/E Ratio1.6x
P/S RatioIs NHNK.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NHNK.Y income statement (TTM) | |
|---|---|
| Revenue | JP¥218.22b |
| Cost of Revenue | JP¥107.50b |
| Gross Profit | JP¥110.71b |
| Other Expenses | JP¥94.54b |
| Earnings | JP¥16.18b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
| Earnings per share (EPS) | 192.81 |
| Gross Margin | 50.74% |
| Net Profit Margin | 7.41% |
| Debt/Equity Ratio | 0.3% |
How did NHNK.Y perform over the long term?
See historical performance and comparison